BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20477902)

  • 1. Identification of a novel antigen cross-presenting cell type in spleen.
    Tan JK; Quah BJ; Griffiths KL; Periasamy P; Hey YY; O'Neill HC
    J Cell Mol Med; 2011 May; 15(5):1189-99. PubMed ID: 20477902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro hematopoiesis produces a distinct class of immature dendritic cells from spleen progenitors with limited T cell stimulation capacity.
    Quah B; Ni K; O'Neill HC
    Int Immunol; 2004 Apr; 16(4):567-77. PubMed ID: 15039387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presenting capacity of murine splenic myeloid cells.
    Hey YY; Quah B; O'Neill HC
    BMC Immunol; 2017 Jan; 18(1):4. PubMed ID: 28077081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCSF drives regulatory DC development in stromal co-cultures supporting hematopoiesis.
    Petvises S; Periasamy P; O'Neill HC
    BMC Immunol; 2018 Jun; 19(1):21. PubMed ID: 29940852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ; O'Neill HC
    Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic stem cells in spleen have distinct differentiative potential for antigen presenting cells.
    Tan JK; O'Neill HC
    J Cell Mol Med; 2010 Aug; 14(8):2144-50. PubMed ID: 19799644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter.
    Yrlid U; Wick MJ
    J Immunol; 2002 Jul; 169(1):108-16. PubMed ID: 12077235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells in germ-free and specific pathogen-free mice have similar phenotypes and in vitro antigen presenting function.
    Walton KL; He J; Kelsall BL; Sartor RB; Fisher NC
    Immunol Lett; 2006 Jan; 102(1):16-24. PubMed ID: 16105690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serpinb9 (Spi6)-deficient mice are impaired in dendritic cell-mediated antigen cross-presentation.
    Rizzitelli A; Meuter S; Vega Ramos J; Bird CH; Mintern JD; Mangan MS; Villadangos J; Bird PI
    Immunol Cell Biol; 2012 Oct; 90(9):841-51. PubMed ID: 22801574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct responses of splenic dendritic cell subsets to infection with Listeria monocytogenes: maturation phenotype, level of infection, and T cell priming capacity ex vivo.
    Mitchell LM; Brzoza-Lewis KL; Henry CJ; Grayson JM; Westcott MM; Hiltbold EM
    Cell Immunol; 2011; 268(2):79-86. PubMed ID: 21457950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical advance: in vitro production of distinct dendritic-like antigen-presenting cells from self-renewing hematopoietic stem cells.
    Hinton RA; O'Neill HC
    J Leukoc Biol; 2012 Feb; 91(2):341-6. PubMed ID: 22075929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
    Neuenhahn M; Busch DH
    Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8alpha(-) and CD8alpha(+) subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo.
    De Smedt T; Butz E; Smith J; Maldonado-López R; Pajak B; Moser M; Maliszewski C
    J Leukoc Biol; 2001 Jun; 69(6):951-8. PubMed ID: 11404381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spleen stroma maintains progenitors and supports long-term hematopoiesis.
    O'Neill HC; Griffiths KL; Periasamy P; Hinton RA; Petvises S; Hey YY; Tan JK
    Curr Stem Cell Res Ther; 2014; 9(4):354-63. PubMed ID: 24745998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status.
    Mittag D; Proietto AI; Loudovaris T; Mannering SI; Vremec D; Shortman K; Wu L; Harrison LC
    J Immunol; 2011 Jun; 186(11):6207-17. PubMed ID: 21515786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.